Despite billions of dollars of investment, the pharmaceutical industry is struggling to cure major diseases, from cancer to dementia. The average time taken to develop a drug is over 12 years and often far longer, and costs over $1bn. Nine out of ten drugs developed fail to win regulatory approval — and many drug candidates never move from “bench to bedside”, with only around 500 of the thousands of diseases in existence having an approved treatment.
The problem? A failure to adopt engineering techniques like simulation and modelling. Can generative AI change the drug discovery game? Follow the link to read the full article.
